US stocks fluctuate | Promotion of weight loss drugs under Hims & Hers Health receives FDA warning Hims & Hers Health(HIMS.US) drops more than 7%

According to the Wisdom Financial APP, on Tuesday, Hims & Hers Health (HIMS.US) stock price fell, as of the time of writing, the stock had dropped by over 7%, to $49.99. Prior to this, the company received a formal warning letter from the U.S. Food and Drug Administration (FDA) for its promotional content regarding its "complexissimus amerigreptin" product.